Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 5.93% is 42% below its 5-year average of 10.24%, near the low end of its 5-year range (2.91%–14.01%).
As of the fiscal period ended Tuesday, June 30, 2026. 22.77% below its 12-month average of 7.68%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 5.93%.
RETURN ON INVESTED CAPITAL (ROIC)
5.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
10.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
10.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
5.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-22.77%
CURRENT VS 3Y AVG
-42.97%
CURRENT VS 5Y AVG
-42.05%
CURRENT VS 10Y AVG
+8.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
+120.61%
vs the sector median at left
Amphastar Pharmaceuticals, Inc.
Market Cap
$1.12B
Return on Invested Capital (ROIC)
5.93%
TTM Avg
7.68%
3Y Avg
10.40%
5Y Avg
10.24%
Market Cap
$1.12B
Return on Invested Capital (ROIC)
-6.33%
TTM Avg
-3.44%
3Y Avg
-10.34%
5Y Avg
-8.68%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
20.18%
TTM Avg
20.20%
3Y Avg
19.35%
5Y Avg
14.75%
Market Cap
$1.14B
Return on Invested Capital (ROIC)
-42.98%
TTM Avg
-26.82%
3Y Avg
-23.95%
5Y Avg
-23.95%
Market Cap
$1.14B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.83%
3Y Avg
4.30%
5Y Avg
3.30%
Market Cap
$1.16B
Return on Invested Capital (ROIC)
3.72%
TTM Avg
3.50%
3Y Avg
1.32%
5Y Avg
-2.22%
Market Cap
$1.05B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$1.20B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.04B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | $1.12B | 5.93% | 7.68% | 10.40% | 10.24% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.12B | -6.33% | -3.44% | -10.34% | -8.68% |
| IRadimed Corporation (IRMD)vs › | $1.11B | 20.18% | 20.20% | 19.35% | 14.75% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.14B | -42.98% | -26.82% | -23.95% | -23.95% |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 1.81% | 7.83% | 4.30% | 3.30% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 3.72% | 3.50% | 1.32% | -2.22% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -7.32% | -21.18% | -91.27% | -61.58% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.20B | -67.73% | -67.73% | -67.73% | -67.73% |
| Immatics N.V. (IMTX)vs › | $1.04B | -53.36% | -19.72% | -15.42% | -34.93% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | 20.01% | 1.42% | 2.77% | 3.34% |
ROIC
5.9%
ROE
10.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 5.93% |
| 2026-03-31 | 6.02% |
| 2025-12-31 | 7.56% |
| 2025-09-30 | 8.39% |
| 2025-06-30 | 10.50% |
| 2025-03-31 | 11.18% |
| 2024-12-31 | 12.34% |
| 2024-09-30 | 13.10% |
| 2024-06-30 | 14.01% |
| 2024-03-31 | 13.49% |
| 2023-12-31 | 12.42% |
| 2023-09-30 | 11.20% |
| 2023-06-30 | 9.09% |
| 2023-03-31 | 13.84% |
| 2022-12-31 | 13.15% |
| 2022-09-30 | 11.45% |
| 2022-06-30 | 12.16% |
| 2022-03-31 | 10.49% |
| 2021-12-31 | 9.25% |
| 2021-09-30 | 6.52% |
| 2021-06-30 | 2.91% |
| 2021-03-31 | 1.42% |
| 2020-12-31 | 1.13% |
| 2020-09-30 | 0.89% |
| 2020-06-30 | 0.71% |
| 2020-03-31 | 1.58% |
| 2019-12-31 | -0.01% |
| 2019-09-30 | 0.27% |
| 2019-06-30 | 0.29% |
| 2019-03-31 | -0.43% |
| 2018-12-31 | -2.04% |
| 2018-09-30 | -2.95% |
| 2018-06-30 | -4.51% |
| 2018-03-31 | -3.19% |
| 2017-12-31 | -0.23% |
| 2017-09-30 | -0.97% |
| 2017-06-30 | 0.84% |
| 2017-03-31 | 2.50% |
| 2016-12-31 | 2.97% |
| 2016-09-30 | 6.39% |
| 2016-06-30 | 5.01% |
| 2016-03-31 | 1.30% |
| 2015-12-31 | -2.02% |
| 2015-09-30 | -8.34% |
| 2015-06-30 | -9.46% |
| 2015-03-31 | -6.91% |
| 2014-12-31 | -5.38% |
| 2014-09-30 | -2.31% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 2.71% |
| 2013-12-31 | 4.08% |
| 2013-09-30 | 5.24% |
